. Purpose: This study aimed to examine the clinical effect of cardiorespiratory fitness (CRF) and improvements in CRF after cardiac rehabilitation (CR) in heart failure (HF) patients for their risk for all-cause mortality and unplanned hospitalization and to investigate possible factors associated with the absence of improvement in CRF after rehabilitation. Methods: We included 155 HF patients receiving CR between October 2009 and January 2015. Patients performed an incremental bicycle test to assess CRF through peak oxygen uptake (V O 2 -peak) before and after CR-based supervised exercise training. Patients were classified as responders or nonresponders on the basis of pre-to-post CR changes in V O 2 -peak (Q6% and G6%, respectively). Cox proportional hazards models evaluated all-cause mortality and unplanned hospitalization during 5 yr of follow-up. Patient characteristics, HF features, and comorbidities were used to predict changes in V O 2 -peak using logistic regression analysis. Results: Seventy HF patients (45%) were classified as responder. Nonresponders had a significantly higher risk for all-cause mortality or hospitalization (hazard ratio, 2.15; 95% confidence interval (CI), 1.17-3.94) compared with responders. This was even higher in nonresponders with low CRF at baseline (hazard ratio, 4.88; 95% CI, 1.71-13.93). Factors associated with nonresponse to CR were age (odds ratio (OR), 1.07/yr; 95% CI, 1.03-1.11), baseline V O 2 -peak (OR, 1.16 mLImin j1 Ikg j1 ; 95% CI, 1.06-1.26), and adherence to CR (OR, 0.98/percentage; 95% CI, 0.96-0.998). Conclusions: Independent from baseline CRF, the inability to improve V O 2 -peak by CR doubled the risk for death or unplanned hospitalization. The combination of lower baseline CRF and nonresponse was associated with even poorer clinical outcomes. Especially older HF patients with higher baseline V O 2 -peak and lower adherence have a higher probability of becoming a nonresponder.
H eart failure (HF) is diagnosed in 1%-2% of the adult population of developed countries and is characterized by a structural or functional impairment of ventricular filling or ejection (1, 2) . HF patients typically suffer from dyspnea and fatigue, which may limit their habitual physical activity and contribute to exercise intolerance. Hence, the cardiorespiratory fitness (CRF) of HF patients is lower compared with age-and sex-predicted reference values (3, 4) .
Previous studies indicated that CRF is an important predictor for the course of disease (5, 6) , with lower CRF being related to an increased risk for cardiovascular events. Improvement of CRF through exercise training is therefore recommended in HF patients (1, 2) .
Previous studies in HF patients suggest a potential decline in mortality and hospitalization rate after standardized cardiac rehabilitation (CR; involving exercise training) compared with usual care (7, 8) . However, significant heterogeneity exists in individual responses to CR, with some demonstrating no change or even a decline in fitness. It has been estimated that only half of the HF patients improve their fitness after standardized CR (9,10) compared with 86% in non-HF individuals (11) . Evidence is limited whether the absence of improvement affects future survival and morbidity. Preliminary work suggests that HF patients with an increased fitness after CR (responders) have a lower risk for all-cause mortality and hospitalization compared with patients without such improvements (nonresponders) (9) . Likewise, nonresponders demonstrated an increased risk for cardiac events compared with responders (10) . These studies were, however, limited by a low adherence (40%) to the exercise training sessions. Moreover, the work related to a specific population of HF patients (i.e., young (systolic) HF patients) and relatively short follow-up (9, 10) . Given the overall health benefits of CR-based exercise programs and the high number of nonresponders, it is relevant to better understand the clinical effect of being a nonresponder and to identify HF patients who are at particular risk for becoming a nonresponder.
Therefore, the aim of our study was to compare the risk for morbidity and all-cause mortality between HF patients responding and nonresponding in CRF improvement after standardized and supervised exercise training as part of a CR program. We expect that improvement in CRF after rehabilitation is associated with a reduced risk for morbidity and all-cause mortality, whereas this observation is independent of prerehabilitation levels of CRF. Furthermore, to better understand the characteristics of a nonresponder, we aimed to predict which HF patients will become a nonresponder to CR using personal-, health-, disease-and exercise trainingrelated characteristics.
METHODS
Subjects. All HF patients who followed supervised exercise training as part of a CR program at the Radboud University Medical Center or Isala Clinic between October 2009 and January 2015 were eligible for participation in the study. Both patients with a reduced ejection fraction (HFrEF) and a preserved ejection fraction (HFprEF) were included if they performed a baseline and follow-up fitness test. HF patients with a peak respiratory exchange ratio (RER) of G1.00 at baseline and/or posttraining exercise test were excluded from the study to guarantee the quality of the included data.
Experimental design. At baseline and after completion of the exercise training program, HF patients underwent cardiopulmonary exercise testing to determine changes in CRF. Absolute change in physical fitness was assessed by calculation of the difference in peak oxygen uptake (V O 2 -peak) between both exercise tests. Relative change was calculated by dividing the absolute change by the baseline V O 2 -peak. HF patients were classified as responder if they demonstrated a relative improvement in a V O 2 -peak of Q6% and as nonresponder if the increase in V O 2 -peak was G6%. The threshold of 6% improvement was used to compensate for intertest variability, and an increase of V O 2 -peak of Q6% was considered a meaningful and reliable difference (12) .
Data related to patient characteristics, unplanned hospitalization, and all-cause mortality were extracted from electronic patient files at both hospitals. The local committee on research involving human subjects of the region Arnhem and Nijmegen approved the study, and the study adhered to the Declaration of Helsinki.
Exercise training programs. HF patients participated in four different supervised exercise training programs, depending on year of participation and the available program at the medical center. Patients from the Radboud University Medical Center participated in 1) an 8-wk exercise program, consisting of two sessions per week at a moderate exercise intensity (n = 23), or 2) a 12-wk exercise program, consisting of two sessions per week at moderate (n = 10) or high exercise intensity (n = 10). Patients from the Isala Clinic participated in 3) a 12-wk exercise program, consisting of two sessions per week at a moderate exercise intensity (n = 36), or 4) a 24-wk exercise program (n = 76), consisting of two sessions per week at a moderate exercise intensity. Moderate intensity was defined as BORG rating scale of perceived exertion of 11-15. During high-intensity training sessions, 10 bouts of 1-min at 90% of the maximal workload were alternated by 2.5 min at 30% of the maximal workload. Adherence of HF patients to the exercise program was defined as the total number of training sessions performed by a patient divided by the total number of training sessions in the program. This ratio was multiplied by 100 to obtain a percentage.
Cardiopulmonary exercise test. Standardized exercise testing was performed on a bicycle ergometer with increasing workload until exhaustion. The oxygen consumption was measured by an automated system, which was calibrated before every test with both ambient air and a fixed known gas mixture. During exercise testing, subjects were verbally encouraged to achieve maximum exertion, evidenced by a RER of Q1.00. Respiratory gas analysis measured the oxygen uptake, carbon dioxide production, and ventilation. Gas exchange results were used to determine the V O 2 -peak, which was defined as the average V O 2 over the last 30 s of the exercise test. The maximal heart rate and workload (watts) were measured during the exercise test.
Data extraction. Electronic patient files were used to collect 1) baseline patient characteristics including age, sex, body mass index (BMI), current smoking status, and comorbidities (diabetes mellitus, chronic obstructive pulmonary disease, and hypertension), and 2) HF characteristics such as disease etiology (ischemic vs nonischemic), New York Heart Association (NYHA) classification, left ventricular ejection fraction, history of atrium fibrillation, medication use (angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, beta-blocker agent, aldosterone receptor antagonist, loop diuretic, and statins), and the presence of medical devices (pacemaker, cardiac resynchronization therapy, or implantable cardioverter-defibrillator). Furthermore, we used all-cause unplanned hospitalization events and all-cause mortality as our end points and obtained these from the electronic patient files.
Data analysis. Kaplan-Meier curves and the log-rank test were used to assess the difference in clinical outcome between responders and nonresponders. The end point was any unplanned hospitalization or all-cause mortality. Patients who did not reach the end point were censored at the end of the observation period or after 5 yr of follow-up. The follow-up started at the baseline cardiopulmonary exercise test before CR. The crude hazard rate ratio (HR) with 95% confidence interval (CI) was calculated first by using univariable Cox proportional hazards modeling. Subsequently, we compared patient characteristics, HF characteristics, medication use, medical devices, and physiological variables between groups using the chi-squared test for categorical variables, Student_s t-test for normally distributed continuous variables and the Mann-Whitney U test for not normally distributed continuous variables. We adjusted the survival analysis with multivariable Cox proportional hazards modeling for the following possible confounding factors: age, sex, BMI, baseline V O 2 -peak, and a cardiac resynchronization therapy combined with implantable cardioverter-defibrillator. The adjusted HR was calculated with a 95% CI.
To calculate the odds of becoming a nonresponder, we used univariable logistic regression and examined the following factors: age, sex, BMI, current smoking status, comorbidities, disease etiology, NYHA classification, ejection fraction, history of atrium fibrillation, medication use, the presence of medical devices (pacemakers, cardiac resynchronization therapy, or implantable cardioverter-defibrillator), adherence, duration and type of the rehabilitation program, and baseline values of V O 2 -peak, maximum achieved heart rate, and peak workload. The potential factors were entered into a hierarchical multivariable logistic regression model using different blocks. In all blocks, backward selection was used with stepwise removal at P = 0.10 to identify the most predictive variables. The discriminative performance of the model was assessed by calculating the area under the receiver operating characteristic curve (AUC).
To calculate the necessary sample size, we performed a power calculation using a power of 80%, an overall type 1 error of 0.05 (two-sided), and as clinically relevant effect size an HR of 2. Approximately 145 subjects were needed to obtain the number of required events (n = 71) (13) . To develop a prediction model, we used the rule of thumb with minimal 10 events per variable for obtaining a good prediction (14, 15) . Statistical analyses were performed in SPSS 20.0. P G 0.05 was considered statistically significant.
RESULTS
Study population. A total of 187 HF patients met the inclusion criteria of our study. After inspection for data quality, 32 patients were excluded because of a maximal RER of G1.00 during the maximal exercise test. As a result, 155 patients were available for analysis (Fig. 1) , with a median adherence to the supervised training sessions of 88% and interquartile range of 79%-96%.
Responders versus nonresponders. Seventy HF patients (45%) were classified as responder (see Figure, Supplemental Digital Content 1, Relative difference in V O 2 -peak (%) between baseline and post exercise training values, http://links.lww.com/MSS/B58. Responders are presented in dark gray and nonresponders in light gray. The dashed line represents a 6% improvement in V O 2 -peak, which was the cut point for being a responder or nonresponder). Nonresponders were more frequently men, had a lower adherence to the rehabilitation program, had a higher baseline V O 2 -peak, had and a lower posttraining V O 2 -peak compared with responders (Table 1) . Age, BMI, current smoking behavior, and the duration of the rehabilitation program did not differ between the groups.
Likewise, no differences in HF characteristics, comorbidities, medication use, medical devices, and other physiological data were found.
All-cause mortality and unplanned hospitalization. One hundred forty-three of 155 HF patients were included in the survival analysis, because the follow-up data of 12 patients were not accessible for data protection reasons. In total, 57 HF patients died or had an unplanned hospitalization: 36 nonresponders (46%) and 21 responders (33%). The median follow-up period was 23 months (interquartile range, 13-47) for nonresponders and 30 months (15-50) for responders. Figure 2 shows the Kaplan-Meier curves for time to unplanned hospitalization or death (P = 0.12). Nonresponders had a 52% higher risk for death or unplanned hospitalization than did responders (HR, 1.52; 95% CI, 0.89-2.61). The multivariable Cox proportional hazards regression analysis showed that the risk for death or unplanned hospitalization was more than twice as high in nonresponders (HR, 2.15; 95% CI, 1.17-3.94) after adjustment for age, sex, BMI, baseline V O 2 -peak, and a cardiac resynchronization therapy combined with implantable cardioverter-defibrillator. Subgroup analyses did not show any difference in results for patients with HFrEF or HFprEF at baseline.
A lower baseline CRF level (V O 2 -peak G16.5 mLImin j1 Ikg j1 ) was associated with a 2.76 (95% CI, 1.52-5.05) increased risk for all-cause mortality and unplanned hospitalization after adjustment for age, sex, BMI, and response status. Conversely, after adjustment for age, sex, BMI, and CRF level, nonresponders had a 1.80 (95% CI, 1.02-3.18) higher risk for all-cause mortality and unplanned hospitalization. Nonresponders with the lowest baseline CRF had a 4.88 (95% CI, 1.71-13.93) higher risk for all-cause mortality or unplanned hospitalization compared with responders with a high baseline CRF level (Fig. 3) . Predicting response to exercise training. We identified age, sex, etiology of HF, use of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker, loop diuretics, pacemaker, baseline V O 2 -peak, and adherence to the exercise program as potential factors associated with becoming a nonresponder to CR-based exercise training (see Table, ; 95% CI, 1.06-1.26), and adherence to the exercise program (OR, 0.98/ percentage; 95% CI, 0.96-0.998) were associated with being a nonresponder. The performance of the prediction model is shown in Figure 4 and demonstrates an AUC of 0.73 (95% CI, 0.65-0.82).
DISCUSSION
As many as 55% of 155 HF patients did not increase V O 2 -peak after supervised exercise training sessions in a CR program. More importantly, HF patients classified as nonresponders to CR had a 2.15 times higher risk for all-cause mortality or unplanned hospitalization compared with responders after adjustment for possible confounders. The increased risk for all-cause mortality or unplanned hospitalization for nonresponders was independent of prerehabilitation CRF levels. In addition, nonresponders with lower CRF levels had the worst prognosis for unplanned hospitalization and all-cause mortality. Taken together, our data reinforce the clinical importance of baseline CRF levels and the ability to improve fitness after exercise training. To predict nonresponse to CR, we found that higher age, lower adherence, and higher baseline V O 2 -peak were significantly associated with nonresponse status.
Nonresponse, all-cause mortality, and unplanned hospitalization. We found that 85 HF patients (55% of study population) were classified as nonresponders to exercise training. Although this prevalence is remarkably high, our findings are in line with most (50%-56% nonresponders) (9,10), but not all (0.9% nonresponders) (16) , studies assessing changes in V O 2 -peak after CR. The conflicting outcomes are probably related to the definition of being a nonresponder. For example, the study of Leifer et al. (16) with a prevalence of 0.9% nonresponders defined nonresponse as a decrease in V O 2 -peak . HR values were adjusted for age, sex, and BMI. FIGURE 2-Kaplan-Meier curves of the time to death or unplanned hospitalization in 143 HF patients. In total, 57 HF patients were hospitalized or died during follow-up: 36 nonresponders (46%) and 21 responders (33%). The crude 5-yr probability for all-cause mortality or unplanned hospitalization was 41% for responders and 56% for nonresponders (log-rank test, P = 0.12).
, whereas we and others (9,10) defined nonresponse as a lack of increase in V O 2 -peak after exercise training. Nonetheless, our data provide further evidence that the presence of nonresponders in HF patients who participate in CR programs is larger than typically observed in a healthy patient cohort.
In line with our observations, previous work found that HF patients benefit from exercise training (7, (17) (18) (19) . Data from the HF-ACTION trial revealed a 5% higher risk for allcause mortality or all-cause hospitalization in nonresponders compared with responders after 3 yr of follow-up (9) . The benefits of V O 2 -peak improvement were much larger in our study population because we found a 2.15 higher risk (HR, 2.15; 95% CI, 1.17-3.94) for all-cause mortality or unplanned hospitalization in nonresponders versus responders after 5 yr of follow-up. However, comparison between the HF-ACTION trial and this study is limited because HF-ACTION only included HFrEF patients and this study included both HFrEF and HRprEF. In addition, apart from a longer follow-up time, the difference in risk reduction between our study and HF-ACTION may also relate to study cohort characteristics. Compared with the HF-ACTION trial, our HF patients were more often classified as NYHA classification I or II, showed a lower prevalence of ischemic etiology and a higher baseline V O 2 -peak (16.5 vs 15.0 mLImin ), and had a relatively high adherence (median, 88%). These factors (i.e., lower NYHA classification, nonischemic etiology [20] , higher CRF [6] ) are typically associated with better survival in HF patients. This suggests that less severe HF patients may have greater health benefits from CRF improvements after CR. Future studies are required to better understand this relation.
In examining the benefits of CR, it is important to take prerehabilitation levels of fitness into consideration because previous work found that fitness may represent the strongest predictor for (all-cause) mortality and morbidity in HF patients (5, 6) . In agreement with this previous research, we found that baseline fitness levels are strongly and independently related to mortality or hospitalization. Taking both baseline fitness and change in fitness postrehabilitation into consideration, we found that nonresponders with lower fitness levels had the highest risk for adverse clinical outcomes. These data show for the first time that both lower baseline fitness levels and nonresponse to CR are independently and in combination associated with an increased risk for adverse events in HF patients.
Prediction of nonresponse. In this study, we tried to identify factors that predict nonresponse to exercise training in HF patients, because this response is related to future adverse events. We demonstrated that older HF patients with a relatively high baseline V O 2 -peak and lower adherence were more often nonresponders. These findings align with observations from other studies. A meta-analysis in HF patients showed that lower age was associated with larger improvements of V O 2 -peak (21) . Also, HF patients with higher V O 2 -peak (22, 23) had smaller improvements in fitness after exercise training. Medication use was not associated with response status and did not significantly change during CR within both groups. Therefore, we do not expect an interaction of medication in relation to performance outcomes. Our prediction model had an AUC of 0.73, which indicates that the discriminative power of our model is not sufficient for direct implementation in clinical practice. Nonetheless, we have identified factors that significantly contribute to the prediction whether CRF improves after training. The addition of chonotropic incompetence (24) and parameters reflecting severe hemodynamic dysfunction (25, 26) and cardiac dimensions (27, 28) may further improve its predictive capacity and warrant further investigation.
Clinical relevance. The observation that nonresponse to CR training is related to increased all-cause mortality or hospitalization has important clinical consequences. Independent of baseline fitness levels, the inability to improve fitness after exercise training increases the risk for adverse events. Especially nonresponders with lower baseline fitness are at high risk for adverse events. This further emphasizes the importance of nonresponse in CR. Nonmodifiable factors (age, baseline V O 2 -peak) contribute to early identification, which may lead to the prescription of a different type of CR. For example, nonresponders might benefit from other types of exercise interventions such as high-intensity interval training or resistance training to improve their physical fitness. Literature revealed that HF patients performing highor vigorous-intensity exercise programs have a higher increase in the V O 2 -peak compared with moderate-intensity programs (17, 29) and are less likely to show a nonresponse to training. Resistance exercise improves muscle mass, strength, and muscular fitness in HF patients (30) (31) (32) and therefore might increase cardiovascular fitness by optimizing the response to aerobic conditioning. In fact, the combination of aerobic and resistance exercise training seemed to be superior for improving submaximal exercise capacity and health-related quality of life compared with aerobic exercise only (33) . In addition, HF patients who remain to be nonresponders may have to increase training frequency (34) . Such approaches may contribute to a reduction of future adverse events in this vulnerable group. Finally, strong adherence to exercise training should be encouraged in HF patients, because adherence is a significant and, more importantly, modifiable factor for being a nonresponder to CR.
Strengths and limitations. This study included typical HF outpatients, which increases the external validity of our study. In addition, there were no dropouts during follow-up, which means that all censoring was noninformative and therefore unrelated to patient prognosis. A limitation of our study may relate to the exclusion of 17% of eligible HF patients because of an insufficient RER during the exercise test. However, to guarantee the quality of the achieved maximal V O 2 and thereby the stratification into responder versus nonresponder, it was inevitable to exclude those patients. Furthermore, it was not feasible to use standardized meals before exercise testing. Also, no data about diet or water consumed before the exercise test, which may influence the V O 2 -peak, were available.
CONCLUSIONS
Nonresponders to exercise training had a 2.15 higher risk for all-cause mortality or unplanned hospitalization compared with responders after adjustment for possible confounders, a finding independent from other prognostic markers for adverse events (including baseline levels of fitness). This observation is of clinical importance since half of the HF patients participating in a CR-based supervised exercise training program was unable to significantly improve V O 2 -peak. Higher age and baseline V O 2 -peak and lower adherence were identified as independent factors associated with nonresponse to CR-based exercise training in HF patients.
